IRIS
BRILLANTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.782
EU - Europa 3.673
AS - Asia 2.330
SA - Sud America 474
Continente sconosciuto - Info sul continente non disponibili 223
AF - Africa 165
OC - Oceania 5
AN - Antartide 1
Totale 12.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.662
IT - Italia 887
GB - Regno Unito 735
SG - Singapore 721
RU - Federazione Russa 669
CN - Cina 639
IE - Irlanda 531
BR - Brasile 399
FR - Francia 301
KR - Corea 301
VN - Vietnam 213
HK - Hong Kong 211
UA - Ucraina 144
SE - Svezia 121
ZA - Sudafrica 90
DE - Germania 86
FI - Finlandia 85
CA - Canada 66
BD - Bangladesh 44
IN - India 41
NG - Nigeria 32
AR - Argentina 29
TR - Turchia 29
MX - Messico 27
JP - Giappone 23
NL - Olanda 20
IQ - Iraq 19
ES - Italia 18
BE - Belgio 14
EG - Egitto 14
AT - Austria 13
EC - Ecuador 13
ID - Indonesia 12
IR - Iran 11
KE - Kenya 11
PL - Polonia 10
CL - Cile 9
PK - Pakistan 9
CO - Colombia 8
UZ - Uzbekistan 8
PE - Perù 7
PT - Portogallo 7
CH - Svizzera 6
NP - Nepal 6
SA - Arabia Saudita 6
JM - Giamaica 5
MA - Marocco 5
MY - Malesia 5
AU - Australia 4
DZ - Algeria 4
HN - Honduras 4
LB - Libano 4
LT - Lituania 4
PH - Filippine 4
PY - Paraguay 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
GR - Grecia 3
JO - Giordania 3
KZ - Kazakistan 3
PR - Porto Rico 3
RO - Romania 3
TN - Tunisia 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BO - Bolivia 2
HR - Croazia 2
LV - Lettonia 2
OM - Oman 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
ET - Etiopia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HT - Haiti 1
KG - Kirghizistan 1
KI - Kiribati 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
Totale 12.428
Salva come PNG Salva come JPEG
Città #
Southend 638
Dallas 589
Fairfield 583
Dublin 525
Ashburn 441
Singapore 351
Chandler 324
Santa Clara 282
Woodbridge 269
Milan 259
Seattle 237
Hong Kong 206
Wilmington 203
Cambridge 201
Beijing 180
Houston 180
Jacksonville 176
San Jose 174
Bupyeong-gu 167
Moscow 161
Princeton 132
Council Bluffs 131
Ann Arbor 107
Johannesburg 87
Helsinki 77
Siena 77
Rome 75
The Dalles 73
Lauterbourg 70
Ho Chi Minh City 69
Los Angeles 69
Hefei 65
Secaucus 61
Seoul 61
Columbus 60
Nanjing 51
New York 49
São Paulo 41
San Diego 39
Hanoi 36
San Mateo 36
Gimpo-si 35
Piscataway 33
Abuja 31
Florence 31
London 30
Paris 30
Clifton 29
Turin 28
Boardman 27
Buffalo 26
Shanghai 26
North Bergen 25
Redondo Beach 25
Gwangyang-si 24
Figino 22
Tokyo 20
Dong Ket 18
Bari 17
Bologna 17
Dearborn 17
Izmir 17
Newark 16
Phoenix 16
The Bronx 16
Brasília 15
Frankfurt am Main 15
Hebei 15
Naples 14
Toronto 14
Ascoli Piceno 13
Brooklyn 13
Atlanta 12
Brussels 12
Nuremberg 12
Orem 12
Shenyang 12
Verona 12
Boston 11
Chennai 11
Palermo 11
Bengaluru 10
Chicago 10
Da Nang 10
Munich 10
Nanchang 10
Rio de Janeiro 10
San Francisco 10
Warsaw 10
Belo Horizonte 9
Catania 9
Cupramontana 9
Incheon 9
Macerata 9
Tianjin 9
Cairo 8
Jiaxing 8
Montreal 8
Poplar 8
Vienna 8
Totale 8.566
Salva come PNG Salva come JPEG
Nome #
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 1.001
Western Experience of Hepatolithiasis: Clinical Insights from a Case Series in a Tertiary Center 283
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 270
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 263
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum 259
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 251
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 244
Distribution of three major hepatitis C virus genotypes in Italy. A multicentre study of 49 5 patients with chronic hepatitis C 243
Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis 229
Primary Biliary cholangitis case-finding: an italian multicenter observational study on patients with incidental finding of anti-mithocondrial antibodies 226
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 224
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C 215
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 214
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 212
HCV INFECTION AND CHRONIC ACTIVE HEPATITIS IN ALCOHOLICS 200
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy 200
Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C 195
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients 195
HEPATITIS-C VIRUS - A POSSIBLE CAUSE OF CHRONIC HEPATITIS IN ALCOHOLICS 190
Proctosigmoidite ulcerosa refrattaria e recidivante alla terapia topica trattata con beclometasone dipropionato orale 190
Effect of α‐interferon therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis: A quantitative polymerase chain reaction study 186
Incidental findings of anti-mitochondrial antibodies without evidence of Primary Biliary Cholangitis. 183
Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis 179
Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience 178
Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?” 175
EFFECT OF LACTOBACILLUS ACIDOPHILUS AND BIFIDOBACTERIUM BIFIDUM ON RECTAL CELL-KINETICS AND FECAL PH 173
Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation 172
Cell renewal and cancer risk of the stomach: Analysis of cell proliferation kinetics in atrophic gastritis 171
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis 170
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues—A Delphi Consensus Project 166
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 166
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 164
Incidental finding of anti-mitochondrial antibody: a neglected entity needing reappraisal 163
Peginterferon-based therapy for chronic hepatitis C virus infection in patients with normal alanine aminotransferase levels 156
Persistent hepatitis C viraemia without liver disease 154
Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? 154
Ribavirin for chronic hepatitis C: And the mystery goes on 154
Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C 152
LONG-TERM PERSISTENCE OF IGM ANTIBODIES TO HCV IN CHRONIC HEPATITIS-C 150
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations 149
Serum IgM antibodies to hepatitis C virus in acute and chronic hepatitis C 149
Serological and histological aspects of hepatitis C virus infection in alcoholic patients 148
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 147
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3 146
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 145
Spleen stiffness measurements predict the risk of hepatic decompensation after direct-acting antivirals in HCV cirrhotic patients 143
Severe acute autoimmune hepatitis after natalizumab treatment 141
What hides behind an intention-to-treat analysis? 140
Role of amantadine and other adjuvant therapies in the treatment of hepatitis C 139
Management of Delta Hepatitis 45 years after the discovery of HDV 134
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 133
Liver Stiffness Values to Predict Occurrence and Recurrence of Hepatocellular Carcinoma 132
Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study 131
Triple antiviral therapy as a new option for patients with interferon nonresponsive chronic hepatitis C 130
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 124
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 119
Reversibility of gastrointestinal motor abnormalities in chronic intestinal pseudo-obstruction 115
Re-treatment of patients with chronic hepatitis C in clinical practice: Results of a multicenter retrospective survey [Ritrattamento dei pazienti con epatite cronica da HCV nella pratica clinica: Risultati di uno studio multicentrico retrospettivo] 110
Prospective study on the prevalence of HCV infection in consecutive adult inpatients in a hospital division of Internal Medicine in Tuscany 104
Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders 103
RECTAL CELL-PROLIFERATION AND COLON CANCER RISK IN ULCERATIVE-COLITIS 102
Three-year follow-up of chronic hepatitis C patients treated with ribavirin plus interferon-alfa combination therapy: Evidence for long-term efficacy and safety 102
Whipple's disease with melaena and multiple petechial haemorrhages in duodenal mucosa 101
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 95
Trattamento della Epatite da HCV 92
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC 88
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 88
Loss and seroconversion of hepatitis B surface antigen after vaccine therapy in chronic hepatitis B patients treated with nucleoside/nucleotide analogues 87
The role of gut microbiota in chronic liver diseases 84
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy 84
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 75
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 72
La ribavirina nell'epatite cronica C: storia e segreti di un grande successo 71
VIROLOGICAL FAILURES TO NEW DIRECT ACTING ANTIVIRALS IN A REAL LIFE SETTING MAY REQUIRE UNCONVENTIONAL REGIMENS FOR RE-TREATMENT 65
Terapia cellulare in Epatologia 64
Panel discussion 62
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 59
null 10
Totale 12.653
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.017
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022705 0 68 44 54 28 26 37 37 41 78 92 200
2022/20231.021 89 90 124 158 90 237 10 78 83 4 32 26
2023/2024910 63 57 94 103 43 187 232 17 6 33 16 59
2024/20251.628 52 85 166 68 171 112 17 110 135 129 178 405
2025/20264.851 273 552 480 553 594 170 406 166 296 374 410 577
2026/2027378 272 106 0 0 0 0 0 0 0 0 0 0
Totale 12.653